+

WO2019033989A1 - Prothèse de valvule cardiaque - Google Patents

Prothèse de valvule cardiaque Download PDF

Info

Publication number
WO2019033989A1
WO2019033989A1 PCT/CN2018/099680 CN2018099680W WO2019033989A1 WO 2019033989 A1 WO2019033989 A1 WO 2019033989A1 CN 2018099680 W CN2018099680 W CN 2018099680W WO 2019033989 A1 WO2019033989 A1 WO 2019033989A1
Authority
WO
WIPO (PCT)
Prior art keywords
valve prosthesis
heart valve
arm
structures
stent body
Prior art date
Application number
PCT/CN2018/099680
Other languages
English (en)
Chinese (zh)
Inventor
刘明
阳明
陈国明
李�雨
Original Assignee
上海微创心通医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 上海微创心通医疗科技有限公司 filed Critical 上海微创心通医疗科技有限公司
Publication of WO2019033989A1 publication Critical patent/WO2019033989A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue

Definitions

  • the present invention relates to the field of medical device technology, and in particular to a heart valve prosthesis.
  • Aortic regurgitation refers to the flow of blood that has flowed into the aorta back to the left ventricle due to a loosely closed aortic valve during diastole. Mild to moderate aortic regurgitation may have no significant symptoms, and patients with moderate to severe aortic regurgitation may experience a cardiac compensatory period, with an average survival of only 2 to 5 years after loss of compensation.
  • TAVR valves Most of the existing TAVR valves are fixed by stent self-expansion (represented by Medtronic Core-Valve) or balloon-expandable stent (represented by Edwards Sapien), and the stent is fixed with calcified leaflets and annulus; In patients, after the stent itself expands, the calcified leaflets or annulus can hold the stent firmly, and the fixation is achieved by the calcified tissue and the radial support of the stent. From the anatomical features of aortic regurgitation, the primary valve leaf and the aortic root are often not necessarily accompanied by severe calcification, which is flexible, so the traditional TAVR valve cannot be fixed by radial support force.
  • TAVR valves radial support force fixation
  • the overall effect is not good, the valve is prone to turbulence to the ventricular outflow tract, such as Medtronic Core-Valve , DFM, Lotus.
  • TAVR valves for the treatment of aortic regurgitation have become an industry challenge.
  • J-Valve uses the same concept, except that its clips are The valve body is not integral. All of them use transapical implantation, which has a disadvantage of being traumatic compared with the traditional TAVR valve transfemoral implantation.
  • the Edwards HELIO+XT system is based on the original Edwards Sapien-XT valve prosthesis, adding a rigid clamp (HELIO), the clamp is placed in the aortic sinus, and then the Sapien-XT valve is faked. Body release, clamps and valves clamp the native leaflets for fixation.
  • PCR 2013 reports the treatment of aortic regurgitation by transfemoral implantation of the clamp and transapical implantation of the Sapien-XT valve, and it is expected that the implementation of the insertion of the clamp and the valve through the transfemoral approach in the future. It can be found that such a product system is complicated to operate and has high requirements for the operation of a doctor, and there are obvious deficiencies.
  • the present invention provides a heart valve prosthesis for replacing a native valve in a human body, the native valve comprising an annulus, the heart valve prosthesis comprising an expandable stent a body, a prosthetic leaflet fixed to the stent body, and at least one convex structure arranged on a side wall of the stent body; the at least one convexity when the heart valve prosthesis is placed in a human body A structure is provided over the annulus to limit the position of the heart valve prosthesis.
  • the stent body is a mesh column structure
  • the mesh column structure comprises a plurality of meshes
  • the mesh holes are formed by node connections
  • the stent body comprises a first An end portion and a second end portion for extending at the annulus after the heart valve prosthesis is placed in a human body, the second end being provided with an auxiliary unit for connecting A delivery component of the prosthetic delivery system.
  • the heart valve prosthesis has a contracted shape and an expanded configuration, and each of the convex structures can be gathered in a corresponding one of the meshes when the heart valve prosthesis is in a contracted configuration. .
  • the number of the convex structures is plural, and each of the convex structures includes at least two first arm structures and the first arm structure. a second arm structure of the same number, one end of each of the first arm structures is connected to the mesh column structure; the other end of each of the first arm structures is connected to a corresponding one of the second arm structures At one end, the other ends of each of the second arm structures in each of the protruding structures are connected to each other.
  • each of the convex structures includes two of the first arm structure and two of the second arm structures, and the first arm structure
  • the junction with the second arm structure and the junction of the two second arm structures are all circular arc shapes.
  • each of the first arm structures extends radially outward relative to the bracket body, and each of the second arm structures is from a corresponding first The other end of the arm structure extends toward the second end of the bracket body.
  • the native valve further comprises a native leaflet
  • at least one of the convex structures further comprises a cantilever rod, the cantilever rod from the second arm structure The other end extends toward the first end for piercing the native leaflets.
  • the cantilever rod extends in a direction parallel to an axial direction of the stent body.
  • the angle between the first arm structure and the first direction is 30° to 90°, and the second arm structure and the first direction are The angle between the two is -60° to 60°, the first direction is the direction from the first end to the second end and the first direction is parallel to the axial direction of the bracket body.
  • the distance between the second arm structure and the bracket body is 2 mm to 6 mm.
  • the first arm structure connects the end of the bracket body to the bottom of the first end of the bracket body by a distance of 5 mm to 15 mm.
  • the heart valve prosthesis further comprises a skirt structure, the skirt structure is stitched on the inner side wall of the bracket body, and the artificial leaflet is located near One side of the first end.
  • the material of the stent body is nickel titanium alloy.
  • the bracket body is integrally formed with the at least one protruding structure.
  • the position of the heart valve prosthesis is restricted by a convex structure disposed above the annulus, and the deployed shape can be abutted against the annulus under the convex structure.
  • prevent the heart valve prosthesis from agitation effectively solve the anchoring problem of the heart valve prosthesis in the release position under the condition of no calcification of the root of the native valve, and achieve stable implantation of the heart valve prosthesis.
  • the stent body and the convex structure in the invention are small in volume, and are suitable for various transcatheter implantation such as transfemoral implantation, and the wound is small and the operation is simple.
  • FIG. 1 is a schematic front elevational view of a heart valve prosthesis according to an embodiment of the present invention
  • FIG. 2 is a schematic top plan view of a heart valve prosthesis according to an embodiment of the present invention.
  • FIG. 3 is a schematic front elevational view of a heart valve prosthesis and an aorta according to an embodiment of the present invention
  • FIG. 4 is a top plan view of the heart valve prosthesis and the aorta according to an embodiment of the present invention
  • Figure 5 is a schematic front elevational view of a heart valve prosthesis according to another embodiment of the present invention.
  • FIG. 6 is a schematic front elevational view of a conical shaped heart valve prosthesis according to another embodiment of the present invention.
  • FIG. 7 is a schematic top plan view of a conical shaped heart valve prosthesis according to another embodiment of the present invention.
  • Figure 8 is a schematic front elevational view of a heart-shaped heart valve prosthesis of another embodiment of the present invention.
  • FIG. 9 is a schematic top plan view of a heart-shaped valve prosthesis of a wine glass form according to another embodiment of the present invention.
  • Figure 10 is a schematic illustration of a heart valve prosthesis assembled in a sheath tube in accordance with another embodiment of the present invention.
  • the figure shows:
  • 1-stent body 11-first row node; 12-second row node; 13-third row node; 2-prosthetic leaflet; 3-convex structure; 31-first arm structure; 32-second Boom structure; 33-cantilever rod; 4-skirt structure; 5--prosthetic leaflet; 6-valvular ring; 7-watt sinus; 8-aorta; 9-sheath; 10-auxiliary unit.
  • the inventors of the present application have found that the use of a valve fixed solely by radial support force can not achieve good results in the treatment of aortic regurgitation, which is manifested in problems such as instability of anchoring and easy turbulence. Achieve good therapeutic results.
  • the novel valve with the combined leaflet method is used for the treatment of aortic valve regurgitation by the apical method.
  • the wound is large and the operation is complicated.
  • the specific structure is that the structure of the valve leaflet is clamped by the clip.
  • the overall size of the valve is large, and it needs to be adopted.
  • Transapical implantation is more traumatic than conventional TAVR valve transfemoral implantation, which is not conducive to postoperative recovery in elderly patients.
  • the method of implanting the clamp and the valve in a apical manner has a complicated operation and a higher requirement for the doctor, in addition to the traumatic disadvantage of the transfemoral.
  • an embodiment of the present invention provides a heart valve prosthesis for replacing a native valve in a human body, the native valve including an annulus, the heart valve prosthesis including a stent body a prosthetic leaflet fixed to the stent body and a convex structure arranged on the side wall of the stent body; when the heart valve prosthesis is placed into a human body, the convex structure is used for Above the annulus, thereby limiting the position of the heart valve prosthesis, effectively solving the anchoring problem of the interventional prosthetic heart valve prosthesis in the release position without significant calcification at the root of the native valve; With the intervention, the trauma is small, the release of the heart valve prosthesis is simple, and the operation time and the recovery time can be effectively improved.
  • heart valve prosthesis proposed in the present invention is applicable not only to the aortic valve but also to the mitral, tricuspid and pulmonary valves.
  • the present embodiment provides a heart valve prosthesis for replacing a native valve in a human body, for example, instead of a pro-aortic valve located between the aorta and the ventricle, Mitral or tricuspid valve.
  • the primary aortic valve is selected as an example in this embodiment.
  • the native valve includes an annulus 6 and a sinus sinus 7 connected to the annulus 6, and the other end of the sinus 7 is connected to the aorta 8
  • the Valsalva sinus 7 protrudes outward relative to the annulus 6 and the aorta 8. This embodiment will be described in terms of the angle of view of Fig.
  • the heart valve prosthesis includes a stent body 1 , a prosthetic leaflet 2 fixed to the stent body 1 , and a convex structure 3 arranged on a side wall of the stent body 1 , wherein: the prosthetic leaflet 2 For opening when blood flows from the ventricle to the aorta, and closing when blood flows from the aorta to the ventricle; when the heart valve prosthesis is placed into the human body, the convex structure 3 is used to abut the annulus Above the sixth, thereby limiting the position of the heart valve prosthesis, as shown in Figure 3, the convex structure 3 extends radially relative to the stent body until all or part of the Valsal is placed above the annulus 6 In the space formed by the sinus 7, the lower edge of the convex structure 3 can be
  • the position of the heart valve prosthesis is restricted by the convex structure 3 abutting above the annulus, that is, the convex structure is used for relative to the stent body Radially extending until it is caught in the space formed by the sinus sinus 7, when the blood flows back from the aorta 8 to the ventricle, the artificial leaflet 2 is closed, and the convex structure 3 can be responsive to the lower side of the convex structure 3 in the deployed configuration.
  • the bracket body 1 is a mesh column structure formed by connecting a plurality of bracket rods, and the mesh column structure includes a plurality of mesh holes, and the mesh holes are surrounded by the bracket rods, and the bracket rods are arranged.
  • the connection point between them is defined as a node of a mesh column structure, and the mesh hole is formed by a node connection, the bracket body includes a first end portion and a second end portion, and the first end portion is used for propping up
  • On the annulus 6, a radial support force is provided, and the second end is provided with an auxiliary unit 10 for connecting the delivery sheath of the implant delivery system (see part 9 in Fig. 10).
  • each node of the mesh column structure is arranged in a plurality of rows, and the plane of each row of nodes is substantially perpendicular to the axis of the bracket body 1, and the adjacent two rows of nodes are staggered along the circumferential direction of the bracket body 1.
  • the bracket body 1 shown in FIG. 3 starting from the bottom of the first end of the bracket body 1, the first row of nodes 11, the second row of nodes 12, the third row of nodes 13, ... are sequentially included.
  • the number of rows of nodes included in the stent body 1 is determined by the type of implant and design parameters, and the present invention does not limit this.
  • the size of the mesh is determined by the distance between the nodes.
  • the mesh sizes in the same row are basically the same.
  • the native valve further includes a native leaflet 5 extending outwardly from the circumferential side of the annulus 6 in the native aortic valve of the present embodiment, the length of the stent body 1 (ie, axial dimension) Greater than the length of the sinus sinus 7, the stent body 1 extends axially from the aortic annulus 6 to the sinus sinus 7 and further axially to the aorta 8, the stent body 1 With elasticity, the native leaflet 5 is squeezed to the side of the sinus sinus 7.
  • the artificial leaflet 2 is fixed to the inner side wall of the stent body 1 for replacing the native leaflet 5.
  • each of the convex structures 3 includes at least two first arm structures 31 and a second arm structure 32 of the same number as the first arm structures 31, each One end of the first arm structure 31 is connected to the mesh column structure, and the other end of each of the first arm structures 31 is connected to one end of the corresponding one of the second arm structures 32, and the same convex structure.
  • the other ends of each of the second arm structures 32 of 3 are connected to each other.
  • the number of the first arm structure 31 and the second arm structure 32 are two, and the connection between the first arm structure 31 and the second arm structure 32 and two
  • the joints of the second arm structures 32 have a circular arc structure to avoid stress concentration and damage the side walls and annulus of the blood vessel.
  • the side projection of the convex structure 3 has an L-shaped structure, as shown in the lower part of FIG.
  • the L-shape referred to herein is substantially L-shaped, and the angle between the first arm structure 31 and the second arm structure 32 is not necessarily Right angle, as long as the top of the second arm structure 32 does not penetrate the side wall of the blood vessel, for example, the radial distance between the top and bottom of the second arm structure 32 relative to the bracket body 1 may be substantially the same, or the second arm
  • the top of the rod structure 32 may be closer to the stent body 1 in the radial direction relative to the bottom of the second arm structure 32, or the top of the second arm structure 32 relative to the second arm without penetrating the side walls of the vessel
  • the bottom of the rod structure 32 can also be radially further away from the bracket body 1; the first arm
  • the front projections of the structure 31 and the second arm structure 32 are substantially inverted V-shaped or inverted U-shaped structures, as shown in a partially enlarged view in the upper part of FIG.
  • each of the first arm structures. 31 extending radially outward relative to the bracket body 1 , each of the second arm structures 32 facing the said bracket body 1 at an angle from the other end of the corresponding one of the first arm structures 31
  • the two ends extend.
  • the partial stent body on the rear side of the convex structure 3 is not shown in the partial enlarged view.
  • At least one of the protruding structures 3 further includes a cantilever rod 33 from the other end of the second arm structure 32, ie, One end of the two-arm structure 32 connected to each other extends toward the first end for piercing the native leaflets 5, preferably, each of the convex structures 3, two or more The nodes connected to the second arm structure 32 extend out of the cantilever rod 33, and the cantilever rod 33 penetrates the native leaflet 5 to achieve dual fixation of the heart valve prosthesis.
  • the cantilever The extending direction of the rod 33 may be substantially parallel to the axial direction of the bracket body 1.
  • a direction from the first end to the second end is defined herein as a first direction, and the first direction is parallel to an axial direction of the bracket body 1, the first The angle between the arm structure 31 and the first direction is 30° to 90°, and the angle between the second arm structure 32 and the first direction is ⁇ 60° to 60°, that is, the second The arm structure 32 may extend toward the bracket body 1 in a direction in which it is close to the bracket body 1 or may extend away from the bracket body 1.
  • the distance from the second arm structure 32 to the bracket body 1 is 2 mm to 6 mm.
  • the first arm structure 31 is connected to one end of the bracket body 1 to a distance of the bracket body 1 at the bottom of the first end portion of 5 mm to 15 mm.
  • the number of the convex structures 3 is plural, preferably four, uniformly disposed on the outer peripheral surface of the bracket body 1, and the first arm structure 31 and the bracket body 1 included in all the convex structures 3 are The joints are all located on the same plane in the radial direction.
  • the two first arm structures 31 are evenly distributed on the transverse plane of the bracket body 1, more specifically, the first arm structure 31 and the bracket body 1
  • the third row of nodes 13 are connected. As described above, the third row of nodes refers to the nodes on the same week from the bottom of the first end of the bracket body 1 in the third row.
  • the advantage of attaching the first arm structure 31 to the node is that the convex structure 3 is integrally formed with the stent body 1 to improve the connection reliability and to facilitate the compression and contraction of the heart valve prosthesis to the contracted configuration. It will be readily understood that the first boom structure 31 may also be fixed to the node without being fixed to the node.
  • the material of the stent body 1 is preferably a nickel-titanium alloy, has a material memory function, and has good elasticity, which can prevent deformation of the stent body 1 caused by blood pressure, and the stent body 1 is integrated with the convex structure 3 Forming, the entire heart valve prosthesis structure is more reliable, and the surface is smooth, no damage to the blood vessels.
  • the artificial leaflet comprises three single leaves, and the three single leaves are, for example, prepared by the anti-calcification treatment of the pig pericardium material, and are fixed on the stent body by suturing or bonding, mainly distributed in the stent.
  • the first end (inflow path) area of the body As shown in FIG.
  • the heart valve prosthesis further includes a skirt structure 4, the skirt structure 4 is sewn on the inner side wall of the bracket body 1, and is located at the The prosthetic leaflet 2 is adjacent to the side of the first end to prevent leakage of the valve.
  • the prosthetic leaflet 2 is a trilobal valve, and FIG. 2 illustrates its top view.
  • the skirt structure 4 can be prepared from a biocompatible polymer, such as polyethylene terephthalate (PET). It may be a homologous or heterologous biological material preparation.
  • the stent body 1 further has an auxiliary unit 10 near the second end of the aorta. As shown in FIG. 10, the auxiliary unit 10 is used to guide the stent body 1 with the guide rod 9 in the sheath tube in the stent delivery system.
  • the heart valve prosthesis is delivered to the blood vessel through the femoral artery by a stent delivery system.
  • the stent body 1 is self-expanding and has a contracted configuration for delivery and a deployed configuration for release.
  • the stent delivery system and delivery method thereof are known in the art and are not specifically developed herein.
  • each of the first arm structures 31 is connected to the node of the mesh column structure, and the node connected to the first arm structure 31 is located larger than the mesh structure 3 is expanded.
  • the contour of the mesh structure adjacent to the convex structure 3 is large, so that the convex structure 3 can be accommodated in the gap of the mesh column structure of the stent body 1 in the contracted configuration of the entire heart valve prosthesis. in.
  • the outer shape of the contracted body 1 of the present embodiment is not significantly enlarged, and can be transported to the release position via the femoral artery.
  • the bracket body 1 is shaped into a cylindrical shape (as shown in FIGS. 1 to 5), that is, the radial dimension of the first end to the second end is substantially the same.
  • the stent body 1 can also be shaped into a conical shape (as shown in FIGS. 6-7), and the stent body is a vertebral body having a taper of 2 to 5 degrees, that is, a radial dimension of the second end portion.
  • the form can further prevent the bracket body from swaying upward, thereby achieving effective anchoring of the bracket body, or the bracket body 1 can also be shaped into a wine glass shape (eg 8 to 9), that is, the outflow channel of the stent body (the portion close to the side of the aorta 8) is shaped into a large-diameter petal shape.
  • the structure can abut against the ascending aortic vessel wall, which can improve the centering of the stent body and the aortic annulus, and improve the anchoring performance of the stent body.
  • the stent body 1 is expandable, having a contracted configuration of delivery and a deployed expanded configuration.
  • the outwardly convex structure 3 can be accommodated in the gap of the mesh unit of the stent body 1 in the contracted state, and the outer shape of the stent body 1 in the contracted form is not significantly enlarged, and can be transported to the release position via the strand.
  • the bracket body 1 is made of nickel-titanium alloy.
  • the nickel-titanium superelastic alloy is used, and the deformation is up to 8%, which can be completely reduced, and the blood pressure is prevented from deforming the stent body.
  • Figure 3 illustrates the anchoring effect of an exemplary valve prosthesis of the present invention at the aortic root.
  • the first end (inflow channel) of the stent body 1 cooperates with the aortic annulus 6, and the aortic annulus is expanded by the radial supporting force of the stent body; the stent body inflow region
  • the second arm structure of the convex structure 3 can squeeze the native leaflets 5, and the valve prosthesis is anchored at the root of the aorta by the radial fixation force and the integrated fixation effect of the convex structure 3, thereby realizing the stable operation of the valve prosthesis.
  • 4 is a top view of the anchoring effect. As can be seen from FIG.
  • the diameter of the pitch circle formed by the convex structure 3 is much larger than the diameter of the annulus 6, and the convex structure 3 can effectively abut against the lower wall of the V. sinus 7 And the aortic annulus 6 achieves reliable anchoring of the valvular prosthesis.
  • the convex structure 3 is disposed in a curved shape, and the first arm structure 31 extends from the node of the mesh column structure and is connected to the second arm structure 32 in a straight shape to the outside.
  • the second arm structure 32 is connected. It is arranged to extend toward the second end (outflow path) of the stent body, and the convex structure 3 as a whole is shaped like an outwardly extending petal.
  • the height of the bottom of the first protruding portion of the bracket body 1 is 5-15 mm, which can well adapt to the height of the native leaflet 5, and ensure that the convex structure 3 can be accurately matched to the aortic annulus 6 and tile.
  • the sinus 7 is on the lower wall.
  • first arm structure 31 is a straight rod extending from a node of the mesh column structure.
  • second arm structure 32 can also be a straight rod, and a corresponding number of second arm structures 32 and The one arm structure 31 is connected, and the other end of the second arm structure 32 intersects.
  • the above-mentioned convex structure 3 extends from the main structural unit of the stent body 1.
  • the contour diameter of the convex structure is larger than the contour diameter of the first end portion (inflow channel) of the stent body.
  • the contour diameter of the convex structure 3 is 4 to 12 mm larger than the diameter of the first end portion (inflow path) of the stent body 1.
  • the bracket body 1 is made of a nickel-titanium alloy tube, preferably made of a nickel-titanium superelastic tube, and is formed into a developed form by heat treatment, polishing, and the like. Due to the shape memory characteristics of the nickel-titanium alloy, the stent body 1 has a self-expanding property, a contracted form of transport and a released form of release.
  • the convex structure In the contracted configuration of the stent body, the convex structure can be accommodated in the gap of the mesh unit, so that the outer shape of the contracted body of the stent body is not significantly enlarged, and can be transported to the release position via the strand.
  • Figure 10 illustrates the contracted configuration of the stent body in a transport state. After the convex structure 3 is compressed and gathered, it is accommodated in the gap of the adjacent grid unit, and the stent body can be properly loaded in the sheath 9 of the delivery system.
  • the heart valve prosthesis of the present invention can be inserted through the femoral artery and released at the root of the aorta, and the trauma is small compared with the transapical intervention, which can effectively improve the postoperative recovery time.
  • the valve prosthesis of the invention has a one-piece structure, and the valve body can be released only by pulling the sheath tube when the stent body is released, and the operation is simple, and the operation operation can be effectively improved. time.
  • the above embodiments describe the different configurations of the heart valve prosthesis in detail.
  • the present invention includes, but is not limited to, the configurations listed in the above embodiments, and any of the configurations provided by the above embodiments are performed.
  • the contents of the transformation are all within the scope of protection of the present invention. Those skilled in the art can make the same according to the content of the above embodiments.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

L'invention concerne une prothèse de valvule cardiaque pour remplacer une valvule naturelle dans un corps humain. La valvule naturelle comprend un anneau de valvule (6), et la prothèse de valvule cardiaque comprend un corps de stent (1) expansible, des feuillets artificiels (2) fixés sur le corps de stent (1), et au moins une structure faisant saillie vers l'extérieur (3) disposée sur une paroi latérale du corps de stent (1). Après l'implantation de la prothèse de valvule cardiaque dans le corps humain, la ou les structures faisant saillie vers l'extérieur (3) sont disposées au-dessus de l'anneau de valvule pour limiter la position de la prothèse de valvule cardiaque. La structure faisant saillie vers l'extérieur (3) est disposée au-dessus de l'anneau de valvule pour limiter la position de la prothèse de valvule cardiaque. Au moyen du fond de la structure faisant saillie vers l'extérieur (3) venant en butée contre le sommet de l'anneau de valvule (6) sous une forme expansée, la prothèse de valvule cardiaque peut être empêchée de se déplacer vers le ventricule, ce qui permet de résoudre efficacement le problème de l'ancrage de la prothèse de valvule cardiaque dans une position libérée sans provoquer de calcification d'une racine de la valvule, et également d'obtenir l'implantation stable de la prothèse de valvule cardiaque.
PCT/CN2018/099680 2017-08-18 2018-08-09 Prothèse de valvule cardiaque WO2019033989A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710714230.8 2017-08-18
CN201710714230.8A CN109394393A (zh) 2017-08-18 2017-08-18 心脏瓣膜假体

Publications (1)

Publication Number Publication Date
WO2019033989A1 true WO2019033989A1 (fr) 2019-02-21

Family

ID=65362379

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/099680 WO2019033989A1 (fr) 2017-08-18 2018-08-09 Prothèse de valvule cardiaque

Country Status (2)

Country Link
CN (1) CN109394393A (fr)
WO (1) WO2019033989A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022042310A1 (fr) * 2020-08-25 2022-03-03 北京市普惠生物医学工程有限公司 Valve artificielle et système de pose de valve

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110279495B (zh) * 2019-06-25 2022-08-26 陈翔 一种自膨胀心脏瓣膜假体
CN113679509A (zh) * 2020-05-19 2021-11-23 上海微创心通医疗科技有限公司 一种心脏瓣膜假体及其支架和置换系统
CN111616835A (zh) * 2020-06-24 2020-09-04 科凯(南通)生命科学有限公司 一种人工心脏瓣膜的植入装置
WO2022016837A1 (fr) * 2020-07-21 2022-01-27 江苏臻亿医疗科技有限公司 Endoprothèse valvulaire et valvule de cœur artificiel la contenant
CN114681135B (zh) * 2020-12-30 2025-04-25 上海微创心通医疗科技有限公司 一种心脏瓣膜假体
CN114681139B (zh) * 2020-12-31 2025-02-14 沛嘉医疗科技(苏州)有限公司 一种瓣膜支架和假体瓣膜组件
CN113545890B (zh) * 2021-07-07 2022-07-15 云南省阜外心血管病医院 一种新型经导管二尖瓣瓣膜
CN113456300A (zh) * 2021-08-06 2021-10-01 康迪泰科(北京)医疗科技有限公司 一种心脏瓣膜支架及输送装置
CN113662716B (zh) * 2021-09-27 2024-10-11 广东脉搏医疗科技有限公司 一种植入三尖瓣膜装置
CN113730039A (zh) * 2021-10-08 2021-12-03 广东脉搏医疗科技有限公司 一种支架瓣膜
CN117771021A (zh) * 2022-09-21 2024-03-29 宁波健世科技股份有限公司 一种可避免交界处反流的瓣膜假体

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102695475A (zh) * 2009-11-02 2012-09-26 西美蒂斯股份公司 主动脉生物假体及用于其递送的系统
CN103997990A (zh) * 2011-06-21 2014-08-20 托尔福公司 人工心脏瓣膜装置及相关系统和方法
CN104000672A (zh) * 2013-02-25 2014-08-27 上海微创医疗器械（集团）有限公司 心脏瓣膜假体
CN205307151U (zh) * 2016-01-07 2016-06-15 上海市同济医院 一种用于穿刺置入的房室瓣瓣膜支架及其输送系统
WO2016130913A1 (fr) * 2015-02-12 2016-08-18 Medtronic Inc. Ensemble à valve intégrée et procédé de pose et de mise en place d'un ensemble à valve intégrée
WO2017079698A1 (fr) * 2015-11-06 2017-05-11 Micor Limited Prothèse de valvule mitrale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2663257B1 (fr) * 2011-01-11 2016-10-26 Hans Reiner Figulla Prothèse valvulaire destinée à remplacer une valvule auriculo-ventriculaire du coeur
CN202801864U (zh) * 2012-09-21 2013-03-20 沛嘉医疗科技（上海）有限公司 人工心脏瓣膜
US9962260B2 (en) * 2015-03-24 2018-05-08 St. Jude Medical, Cardiology Division, Inc. Prosthetic mitral valve
CN106420114B (zh) * 2016-10-24 2018-06-08 宁波健世生物科技有限公司 一种心脏瓣膜假体
CN106618798B (zh) * 2016-10-24 2019-10-11 宁波健世生物科技有限公司 一种通过室间隔固定的心脏瓣膜假体及其输送和释放方法
CN208799371U (zh) * 2017-08-18 2019-04-30 上海微创心通医疗科技有限公司 心脏瓣膜假体

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102695475A (zh) * 2009-11-02 2012-09-26 西美蒂斯股份公司 主动脉生物假体及用于其递送的系统
CN103997990A (zh) * 2011-06-21 2014-08-20 托尔福公司 人工心脏瓣膜装置及相关系统和方法
CN104000672A (zh) * 2013-02-25 2014-08-27 上海微创医疗器械（集团）有限公司 心脏瓣膜假体
WO2016130913A1 (fr) * 2015-02-12 2016-08-18 Medtronic Inc. Ensemble à valve intégrée et procédé de pose et de mise en place d'un ensemble à valve intégrée
WO2017079698A1 (fr) * 2015-11-06 2017-05-11 Micor Limited Prothèse de valvule mitrale
CN205307151U (zh) * 2016-01-07 2016-06-15 上海市同济医院 一种用于穿刺置入的房室瓣瓣膜支架及其输送系统

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022042310A1 (fr) * 2020-08-25 2022-03-03 北京市普惠生物医学工程有限公司 Valve artificielle et système de pose de valve

Also Published As

Publication number Publication date
CN109394393A (zh) 2019-03-01

Similar Documents

Publication Publication Date Title
US11833038B2 (en) Valve prosthesis and method for delivery
WO2019033989A1 (fr) Prothèse de valvule cardiaque
US20230113881A1 (en) Aortic bioprosthesis and systems for delivery thereof
CN108578016B (zh) 一种经心尖植入式二尖瓣瓣膜装置
CN108156805B (zh) 二尖瓣瓣膜组件
CN112891025B (zh) 瓣膜假体和递送方法
US9119713B2 (en) Transcatheter valve replacement
WO2019062366A1 (fr) Prothèse de valve cardiaque
CN111772878B (zh) 一种心脏瓣膜假体
CN208799371U (zh) 心脏瓣膜假体

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18847085

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18847085

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载